Source: http://www.osi.lv/publikacijas/?op&pg=5&gads=2017&print=1
Timestamp: 2019-04-22 06:31:19+00:00

Document:
41 Conka D.; Avotiņa D.; Baumane L.; Kizane G. Application possibilities of ESR spectroscopy for analysis of carbon based divertor materials. Latvijas Universitātes 75. starptautiskā konference, Analītiskās un fizikālās ķīmijas sekcija, 2017; 31.
42 Heuser J. M.; Zarins A.; Kizane G.; Baumane L.; Knitter R. Advanced Ceramic Breeder Pebbles – Thermal Long-Term and Radiation Stability. The 18th International Conference on Fusion Reactor Materials (ICFRM-18); Aomori, Japan, November 5 - 10, 2017.
43 Zarins A.; Kizane G.; Valtenbergs O.; Cipa J.; Supe A.; Baumane L.; Zolotarjovs A.; Leys O.; Knitter R. RADIOLYSIS OF ADVANCED LITHIUM ORTHOSILICATE PEBBLES WITH ADDITIONS OF LITHIUM METATITANAT. The 18th International Conference on Fusion Reactor Materials (ICFRM-18); Aomori, Japan, November 5 - 10, 2017.
44 Zarins A.; Cipa J.; Valtenbergs O.; Supe A.; Kizane G.; Zolotarjovs A.; Baumane L. Accumulation of radiation-induced defects and radiolysis products in modified tritium breeding ceramics. Institute of Solid State Physics University of Latvia. Abstracts of the 33rd Scientific Conference; Riga, Latvia, February 22– 24, 2017; 26.
45 Avotina L.; Conka D.; Baumane L.; Kizane G. Investigations of paramagnetic defects in carbon based vacuum vessel protection materials. Institute of Solid State Physics University of Latvia. Abstracts of the 33rd Scientific Conference; Riga, Latvia, February 22– 24, 2017; 24.
46 Dimitrijevs P.; Rucins M.; Petricenko O.; Plotniece M.; Gulbe A.; Jackevica L.; Gosteva M.; Bandere D.; Domraceva I.; Pajuste K.; Sobolev A.; Plotniece A. Cytotoxicity, self-assembling and physico-chemical properties of bifunctional lipid-like 4-(N-alkylpyridinium)-1,4-dihydropyridines as putative delivery systems (doi:10.25006/IA.5.S1-A.2.4). 2nd International Conference in Pharmacology “From cellular processes to drug targets”; : Riga, Latvia, October 19-20, 2017.
47 Petricenko O.; K. Pajuste; Rucins M.; Plotniece A.; Cebers A. Influence of structure and physico-chemical properties of synthetic lipid-like pyridinium amphiphiles on formation of magnetic liposomes (doi:10.25006/IA.5.S1-A.2.3). 2nd International Conference in Pharmacology “From cellular processes to drug targets”; Riga, Latvia, October 19-20, 2017.
48 Kl. Pajuste; Rucins M.; Jackevica L.; Kanepe-Lapsa I.; Plotniece M.; Tirzite D.; Muceniece R.; Sobolev A.; Domraceva I.; Pajuste K.; Plotniece A. Development of theranostic nanosystems on the base of amphiphilic 1,4-dihydropyridines with styrylpyridinium moieties (doi:10.25006/IA.5.S1-A.2.1). 2nd International Conference in Pharmacology “From cellular processes to drug targets”; Riga, Latvia, October 19-20, 2017.
49 Stepina E.; Kazoka H.; Veinberg G. Normal-Phase Separation of Racemic Phenylpiracetam on Immobilized Amylose-Based Chiral Stationary Phases. 11th International Scientific Conference "The Vital Nature Sign"; Vilnius, Lithuania, October 19-20, 2017; 10.
50 Petukhov V.; Dmitriev E.V.; Baumane L.; Skalny A.V.; Lobanova Yu. N. Electrogenic metals in epidermis and the synchronous operation of membrane ATPases. 5th European Conference on Clinical and Medical Case Reports (abstract in J. Clin. Case Rep. 2017, 7:8, DOI: 10.4172/2165-7920-C1-011); Paris, France, September 07-08, 2017.
51 Petricenko O.; Dimitrijevs P.; Rucins M.; Jackevica L.; Gulbe A.; Kl. Pajuste; Plotniece M.; Gosteva M.; Tirzite D.; Pajuste K.; Sobolev A.; Domraceva I.; Plotniece A. Lipid-like bifunctional 4-(N-alkylpyridinium)-1,4-dihydropyridines with propargyl moiety: contribution of molecular structure to cytotoxicity, physicochemical and self-assembling properties. 31st Conference of The European Colloid and Interface Society, ECIS-2017; Madrid, Spain, September 3-8, 2017; 30.
52 Bucki R.; Niemirowicz K.; Piktel E.; Głuszek K.; Plotniece A.; Janmey P.A. Przeciwdrobnoustrojowe działanie pochodnych 1,4-dihydropirydyny zimmobilizowanych na powierzchni nanocząsteczek magnetycznych. Książka abstraktów VIII Krajowa Konferencja Nanotechnologii, BNB-P6; Łódź, Polska, 20.06. - 23.06., 2017; 140.
53 Niemirowicz K.; Piktel E.; Głuszek K.; Plotniece A.; Janmey P.A.; Bucki R. Przeciwdrobnoustrojowe działanie pochodnych 1,4-dihydropirydyny zimmobilizowanych na powierzcni nanocząstek magnetycznych. Książka abstraktów VIII Krajowa Konferencja Nanotechnologii, BNB-P5; Łódź, Polska, 20.06. - 23.06., 2017; 139.
54 Dmitrijevs P.; Rucins M.; Petrichenko O. ; Jackevica L.; Gulbe A.; Plotniece M.; Pajuste K.; Sobolev A.; Domracheva I.; Bandere D.; Plotniece A. Bifunctional Lipid-like 4-(N-Alkylpyridinium)-1.4-Dihydropyridines: Contribution of Molecular Structure to Physico-chemical Properties and Cytotoxicity. RSU Zinātniskā konference (http://www.rsu.lv/petnieciba/petniecibas-rezultati/konferencu-materiali/2017-gada-rsu-zinatniskas-konferences-tezes); Rīga, Latvija, 6.- 7. aprīlis, 2017; 236.
55 Pajuste Kl.; Pajuste K.; Rucins M.; Jackevica L.; Kanepe-Lapsa I.; Gosteva M.; Plotniece M.; Dmitrijevs P.; Sobolev A.; Domraceva I.; Plotniece A. Multifunctional cationic amphiphilic 1,4-dihydropyridine derivatives for development of theranostic delivery systems. Abstract of 3rd International Conference “Current Trends in Cancer Theranostics” (CTCT-2017), Poster P02; Pakruojis, Lithuania, June 25-29, 2017; 55.
56 Upmanis T.; Orlova N.; Vorona M.; Kažoka H. Enantioseparation of 4C substituted pyrrolidine-2-ones on polysaccharide type coated chiral stationary phases. In book of abstracts: HPLC 2017. 45th International Symposium on High Performance Liquid Phase Separations and Related Technicques (HPLC2017). June 18-22, 2017; 162.
57 Upmanis T.; Kreicberga A.; Kažoka H. Separation of 1,4-dihydropyridine derivative ahd its oxidized form under reversed-phase mode. In book of abstracts: HPLC 2017. 45th International Symposium on High Performance Liquid Phase Separations and Related Technicques (HPLC2017). June 18-22, 2017; 115.
58 Kažoka H.; Kreicberga A.; Veinberg G.; Vorona M. Stationary phase selection for achiral separation of diastereomeric mixtures. In book of abstracts: HPLC 2017. 45th International Symposium on High Performance Liquid Phase Separations and Related Technicques (HPLC2017). June 18-22, 2017; 111.
59 Beikule A.; Rostoka E.; Sjakste N. The investigation of nitite level fluctuation depending on various factors in Latvian population. VII International Students’ Conference of Young Medical Researchers. Poland, Wroclaw, April 6 - 8, 2017; 119.
60 Beikule A.; Rostoka E.; Sjakste N. The impact of variuous factors in Latvian population on the nitrite level in saliva. RSU Student Conference, Riga, Latvia, April 5, 2017; 347.
61 Smelovs E.; Leonova E.; Sjakste N. 1,4-dihidropiridīnu atvasinājumu mijiedarbība ar DNS un to antioksidantu īpašibu izpēte. RSU zinātniskā konference, Rīga, Latvija, 6.-7. aprīlis, 2017; 194.
62 Švacka A.; Rostoka E.; Jēkabsons K.; Selga T.; Sjakste N. The intracellulat interaction of AV-153 with DNA. 75th Conference of the University of Latvia, Riga, 2017; 82.
63 Celma L.; Rostoka E.; Sokolovska J.; Sjakste N. Nitrate concentration changes in type 1 diabetes in the patients blood and urine. 75th Conference of the University of Latvia, Riga, 2017; 83.
64 Smelovs E.; Leonova E.; Sjakste N. Study of antioxidant properties and interactions with DNA of 1,4-dihydropyridien derivatives using spectroscopic methods. 75th Conference of the University of Latvia, Riga, 2017; 81.
65 Paramonova N.; Sjakste T.; Trampiņa I.; Sjakste N. PSMA6 gene poly(dA:dT) tract genetic variations are associated with autoimmunity-related pathologies in Latvians. 75th Conference of the University of Latvia, Riga, 2017; 80.
66 Leonova E.; Sjakste N. DNA lesions in healthy subjects: a literature review. 75th Conference of the University of Latvia, Riga, 2017; 79.
67 Vāvers E. E1R: jauns pozitīvs allostēriskais sigma-1 receptora modulators. Promocijas darbs farmācijas doktora zinātniskā grāda iegūšanai (Dr. pharm.), Rīgas Stradiņa universitāte, Rīga, 2017.
68 Sokolovs I. (Hetero)aromātisko savienojumu C-H funkcionalizēšana. ķīmijas doktora zinātniskais grāds organiskajā ķīmijā (Dr. chem.), Latvijas Universitāte, Rīga, 2017.
69 Vasiļjeva J. Selēna halogenīdi kā jaunu heterociklisku savienojumu iegūšanas avots. Promocijas darbs ķīmijas zinātņu doktora grāda iegūšanai (Dr.chem.), Latvijas Universitāte, Rīga, 2017.
70 Spura J. Furil(tienil)silāna un –germāna atvasinājumu sintēze, struktūra, ķīmiskās un bioloģiskās īpašības. Promocijas darbs ķīmijas doktora zinātniskā grāda iegūšanai (Dr. chem.), Latvijas Universitāte, Rīga, 2017.
71 Ruciņš M. Farmakoforas grupas saturošu 1,4- dihidropiridīna atvasinājumu dizains un to farmakoloģiskās darbības spektra noteikšana. Promocijas darbs farmācijas doktora zinātniskā grāda iegūšanai (Dr. pharm.), Latvijas Universitāte, Rīga, 2017.
72 Sapijanskaite B.; Mickeviciene K.; *Kantminiene K.; Belyakov S.; Mickevicius V. Synthesis and Heterocyclization of 1-Aryl-2-methyl-4-oxo-1,4,5,6-tetrahydropyridine-3-carboxylates. J. Heterocycl. Chem. 2017, 54(5), 2605-2613.
73 Nguyen T.T.; Grigorjeva L.; *Daugulis O. Aminoquinoline-directed, cobalt-catalyzed carbonylation of sulfonamide sp2 C-H bonds. Chem. Commun. 2017, 53(37), 5136-5138.
74 *Velena A.; Zarkovic N.; Kluša V.; Klimaviciusa L.; Pupure J.; Vigante B.; Duburs G. 1,4-dihydropyridines as tools for mitochondrial medicine against oxidative stress and associated metabolic disorders. Curr. Org. Chem. 2017, 21(20), 2030-2043.
75 *Mishnev A.; Mengots A.; Turks M. Crystal structure of 3,6,6-trimethyl-4-oxo-1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1 H-indazol-7-aminium chloride and its monohydrate. Acta Crystallographica Section E: Crystallographic Communications 2017, 73, 1931-1936.
76 Cipa J.; Kizane G.; Supe A.; Zolotarjovs A.; Zarins A.; Baumane L. Luminescence of x-ray induced radiation defects in modified lithium orthosilicate pebbles with additions of titanium dioxide Rentgeno spindulių sukeltų defektų liuminescencija modifikuotuose ličio ortosilikato rutuliukuose su titano dioksido priedais. Energetika 2017, 63(3), 113-120.
77 Kazak M.; Priede M.; Shubin K.; Bartrum H.E.; Poisson J.-F.; *Suna E. Stereodivergent synthesis of pseudotabersonine alkaloids. Org. Lett. 2017, 19(19), 5356-5359.
78 Šmits G.; Audic B.; Wodrich M.D.; *Corminboeuf C.; Cramer N. A β-Carbon elimination strategy for convenient: In situ access to cyclopentadienyl metal complexes. Chem. Sci. 2017, 8(10), 7174-7179.
79 Kinēns A.; Sejejs M.; Kamlet A.S.; Piotrowski D.W.; Vedejs E.; *Suna E. Development of a chiral DMAP catalyst for the dynamic kinetic resolution of azole hemiaminals. J. Org. Chem. 2017, 82(2), 869-886.
80 Otikovs M.; Andersson M.; Jia Q.; Nordling K.; Meng Q.; Andreas L.B.; Pintacuda G.; Johansson J.; Rising A.; *Jaudzems K. Degree of Biomimicry of Artificial Spider Silk Spinning Assessed by NMR Spectroscopy. Angew. Chem. Int. Ed. 2017, 56(41), 12571-12575.
81 Skvorcova M.; *Jirgensons A. Intramolecular cyclopropylmethylation via non-classical carbocations. Org. Biomol. Chem. 2017, 15(33), 6909-6912.
82 Romanovs V.; Sidorkin V.; Belogolova E.; *Jouikov V. Radical cations of phenyl silatrane. Dalton Trans. 2017, 46(27), 8849-8854.
83 Grammatoglou K.; Bolsakova J.; *Jirgensons A. C-Quaternary alkynyl glycinols via the Ritter reaction of cobalt complexed alkynyl glycols. RSC Adv. 2017, 7(44), 27530-27537.
84 Bobiļeva O.; Ikaunieks M.; Duburs G.; Mandrika I.; Petrovska R.; Klovins J.; *Loža E. Synthesis and evaluation of (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate derivatives as HCA2 receptor agonists. Bioorg. Med. Chem. 2017, 25(16), 4314-4329.
85 Zhao P.; Gvishi R.; Beķere L.; Lokshin V.; Khodorkovsky V.; Hagan D.J.; *Van Stryland E.W. Transient ring opening and closing of a two-photon photochromic molecule utilizing energy transfer. Opt.InfoBase Conf. Papers 2017, Part F41-CLEO_SI 2017.
86 Pustenko A.; Stepanovs D.; *Žalubovskis R.; Vullo D.; Kazaks A.; Leitans J.; Tars K.; Supuran C.T. 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem. 2017, 32(1), 767-775.
87 Sakaine G.; Zemrībo R.; *Šmits G. The first total synthesis of usabamycins a and C. Tetrahedron Lett. 2017, 58(25), 2426-2428.
88 *Sjakste N. Experimental and human population studies of DNA lesions in healthy individuals. Bioplym. Cell 2017, 33(1), 24-33.
89 Bruvere I.; Bisenieks E.; Poikans J.; Uldriķis J.; Plotniece A.; Pajuste K.; Ruciņš M.; Vigante B.; Kalme Z.; Gosteva M.; Domracheva I.; *Velena A.; Vukovic T.; Milkovic L.; Duburs G.; Zarkovic N. Dihydropyridine derivatives as cell growth modulators in vitro. Oxidative Med. Cell. Longevity 2017, 2017.
90 Ivanova J.; Carta F.; Vullo D.; Leitans J.; Kazaks A.; Tars K.; *Žalubovskis R.; Supuran C.T. N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII. Bioorg. Med. Chem. 2017, 25(13), 3583-3589.
91 Ivanova J.; Balode A.; *Žalubovskis R.; Leitans J.; Kazaks A.; Vullo D.; Tars K.; Supuran C.T. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations. Bioorg. Med. Chem. 2017, 25(3), 857-863.
92 *Makrecka-Kuka M.; Volska K.; Antone U.; Vilšķērsts R.; Grinberga S.; Bandere D.; Liepinsh E.; Dambrova M. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol. Lett. 2017, 267, 32-38.
93 Ivanova A.; *Arsenyan P. Synthesis of indolizinium salts. Chem. Heterocycl. Compd. 2017, 53(3), 313-315.
94 *Malina I.; Kampars V.; Turovska B.; Belyakov S. Novel green-yellow-orange-red light emitting donor-π-acceptor type dyes based on 1,3-indandione and dimedone moieties. Dyes Pigm. 2017, 139, 820-830.
95 Petrova E.; Rasiņa D.; *Jirgensons A. N-Sulfonylcarboxamide as an Oxidizing Directing Group for Ruthenium-Catalyzed C–H Activation/Annulation. Eur. J. Org. Chem. 2017, 2017(13), 1773-1779.
96 Maier L.; Khirsariya P.; Hylse O.; Adla S.K.; Černova L.; Poljak M.; Krajcovicova S.; Weis E.; Drapela S.; Soucek K.; *Paruch K. Diastereoselective Flexible Synthesis of Carbocyclic C-Nucleosides. J. Org. Chem. 2017, 82(7), 3382-3402.
97 Leonova E.; Shvirksts K.; Grube M.; Ignatovich L.; Chen C.Y.-C.; Sjakste T.; *Sjakste N. Spectrophotometric study of DNA interactions with ftorafur and its elementoorganic derivatives. Toxicol. Environ. Chem. 2017, 99(4), 601-612.
98 *Zviedre I.I.; Belyakov S.V. N,N-diethylanilinium complex with borodicitric acid: Synthesis and crystal structure. Russ. J. Inorg. Chem. 2017, 62(5), 665-670.
99 *Liepinsh E.; Makarova E.; Sevostjanovs E.; Hartmane D.; Cīrule H.; Zharkova-Malkova O.; Grinberga S.; Dambrova M. Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport. Basic Clin. Pharmacol. Toxicol. 2017, 120(5), 450-456.
100 Skvorcova M.; *Jirgensons A. Amide-Group-Directed Protonolysis of Cyclopropane: An Approach to 2,2-Disubstituted Pyrrolidines. Org. Lett. 2017, 19(10), 2478-2481.
101 *Kronqvist N.; Sarr M.; Lindqvist A.; Nordling K.; Otikovs M.; Venturi L.; Pioselli B.; Purhonen P.; Landreh M.; Biverstal H.; Toleikis Z.; Sjoberg L.; Robinson C.V.; Pelizzi N.; Jornvall H.; Hebert H.; Jaudzems K.; Curstedt T.; Rising A.; Johansson J. Efficient protein production inspired by how spiders make silk. Nat. Commun. 2017, 8.
102 *Zablotskaya A.; Segal I.; Geronikaki A.; Shestakova I.; Nikolajeva V.; Makarenkova G. N-Heterocyclic choline analogues based on 1,2,3,4-tetrahydro(iso)quinoline scaffold with anticancer and anti-infective dual action. Pharmacol. Rep. 2017, 69(3), 575-581.
103 *Vāvers E.; Švalbe B.; Ļauberte L.; Stonans I.; Misane I.; Dambrova M.; Zvejniece L. The activity of selective sigma-1 receptor ligands in seizure models in vivo. Behav. Brain Res. 2017, 328, 13-18.
104 Germini D.; Bou Saada Y.; Tsfasman T.; Ošiņa K.; Robin C.; Lomov N.; Rubtsov M.; Sjakste N.; Lipinski M.; *Vassetzky Y. A One-Step PCR-Based Assay to Evaluate the Efficiency and Precision of Genomic DNA-Editing Tools. Mol. Ther. Methods Clin. Dev. 2017, 5, 43-50.
105 Steffen J.; Krohn M.; Schwitlick C.; Bruning T.; Paarmann K.; Pietrzik C.U.; Biverstal H.; Jansone B.; Langer O.; Pahnke J. Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice. Acta Neuropathol Commun 2017, 5(1), 49.
106 Ivanova A.; Tokmakov A.; Lebedeva K.; Roze M.; Kaulachs I. Influence of the Preparation Method on Planar Perovskite CH3NH3PbI3-xClx Solar Cell Performance and Hysteresis. Latv. J. Phys. Tech. Sci. 2017, 54(4), 58-68.
107 Konrāde I.; Dambrova G.; Dambrova M. Denosumab-induced hypophosphataemia in a case of normocalcaemic primary hyperparathyroidism. Intern. Med. J. 2017, 47(8), 974-975.
108 *Reinholds I.; Pugajeva I.; Perkons I.; Lundanes E.; Rusko J.; Kizane G.; Nikolajeva V.; Mutere O.; Petrina Z.; Baumane L.; Bartkevics V. Erratum to: Decomposition of multi-class pharmaceutical residues in wastewater by exposure to ionising radiation (International Journal of Environmental Science and Technology, (2017), 10.1007/s13762-017-1290-6). Int. J. Environ. Sci. Technol. 2017, 14(8), 1821.
109 *Kūka J.; Makrecka-Kuka M.; Cīrule H.; Grinberga S.; Sevostjanovs E.; Dambrova M.; Liepinsh E. Decrease in Long-Chain Acylcarnitine Tissue Content Determines the Duration of and Correlates with the Cardioprotective Effect of Methyl-GBB. Basic Clin. Pharmacol. Toxicol. 2017, 121(2), 106-112.
110 Zandberga E.; Zayakin P.; Ābols A.; Pupola D.; Trapencieris P.; *Linē A. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells. Cancer Biol. Ther. 2017, 18(8), 596-605.
111 Miele E.; Valente S.; Alfano V.; Silvano M.; Mellini P.; Borovika D.; Marrocco B.; Po A.; Besharat Z.M.; Catanzaro G.; Battaglia G.; Abballe L.; Zwergel C.; Stazi G.; Milite C.; Castellano S.; Tafani M.; Trapencieris P.; Mai A.; *Ferretti E. The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells. Oncotarget 2017, 8(40), 68557-68570.
112 Skvorcova M.; Grigorjeva L.; *Jirgensons A. 1-Amino-1-hydroxymethylcyclobutane derivatives via intramolecular amination of nonclassical cyclopropylmethyl cation. Chem. Heterocycl. Compd. 2017, 53(9), 989-996.
113 *Ošiņa K.; Leonova E.; Isajevs S.; Baumane L.; Rostoka E.; Sjakste T.; Bisenieks E.; Duburs G.; Vigante B.; Sjakste N. Modifications of expression of genes and proteins involved in DNA repair and nitric oxide metabolism by carbatonides [disodium-2,6-dimethyl-1,4-dihydropyridine- 3,5-bis(carbonyloxyacetate) derivatives] in intact and diabetic rats. Arh. Hig. Rada Toksikol. 2017, 68(3), 212-227.
114 *Reinholds I.; Pugajeva I.; Perkons I.; Lundanes E.; Rusko J.; Kizane G.; Nikolajeva V.; Mutere O.; Petrina Z.; Baumane L.; Bartkevics V. Decomposition of multi-class pharmaceutical residues in wastewater by exposure to ionising radiation. Int. J. Environ. Sci. Technol. 2017, 14(9), 1969-1980.
115 *Zvejniece L.; Švalbe B.; Vāvers E.; Makrecka-Kuka M.; Makarova E.; Liepins V.; Kalvinsh I.; Liepinsh E.; Dambrova M. S-phenylpiracetam, a selective DAT inhibitor, reduces body weight gain without influencing locomotor activity. Pharmacol. Biochem. Behav. 2017, 160, 21-29.
116 *Aleksis R.; Oleskovs F.; Jaudzems K.; Pahnke J.; Biverstal H. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity. Biochimie 2017, 140, 176-192.
117 *Liepinsh E.; Makrecka-Kuka M.; Makarova E.; Volska K.; Vilks K.; Sevostjanovs E.; Antone U.; Kūka J.; Vilšķērsts R.; Loļa D.; Loža E.; Grinberga S.; Dambrova M. Acute and long-term administration of palmitoylcarnitine induces muscle-specific insulin resistance in mice. BioFactors 2017, 43(5), 718-730.
118 Sike A.; Wengenroth J.; Upite J.; Bruning T.; Eiriz I.; Santha P.; Biverstal H.; Jansone B.; Haugen H.J.; *Krohn M.; Pahnke J. Improved method for cannula fixation for long-term intracerebral brain infusion. J. Neurosci. Methods 2017, 290, 145-150.
119 Vasiļjeva J.; *Arsenyan P. Synthesis of Se–N+ and Te–N+ bond-containing heterocycles. Chem. Heterocycl. Compd. 2017, 53(10), 1061-1067.
120 Cala-De Paepe D.; Stanek J.; Jaudzems K.; Tars K.; Andreas L.B.; *Pintacuda G. Is protein deuteration beneficial for proton detected solid-state NMR at and above 100 kHz magic-angle spinning?. Solid State Nucl Magn Reson 2017, 87, 126-136.
121 Domracheva I.; Kanepe-Lapsa I.; Jackevica L.; Vasiļjeva J.; *Arsenyan P. Selenopheno quinolinones and coumarins promote cancer cell apoptosis by ROS depletion and caspase-7 activation. LIFE SCI. 2017, 186, 92-101.
122 *Zarins A.; Leys O.; Kizane G.; Supe A.; Baumane L.; Gonzalez M.; Correcher V.; Boronat C.; Zolotarjovs A.; Knitter R. Behaviour of advanced tritium breeder pebbles under simultaneous action of accelerated electrons and high temperature. Fusion Eng Des 2017, 121, 167-173.
123 Lokshin V.; Beķere L.; *Khodorkovsky V. Visual light photoswitches derived from bindone: Toward stabilization of colored photo-isomers. Dyes Pigm. 2017, 145, 570-575.
124 Zhao P.; Gvishi R.; Beķere L.; Lokshin V.; Khodorkovsky V.; Hagan D.J.; *Van Stryland E.W. Transient ring opening and closing of a two-photon photochromic molecule utilizing energy transfer. Conf. Lasers. Electr.-Opt., Proc. 2017, 2017-January, 1-2.
125 Mykhaylychenko S.S.; Pikun N.V.; Rusanov E.B.; Rozhenko A.B.; *Shermolovich Y.G. Synthesis of 2-polyfluoroalkyl-2,3-dihydro-1,3,4-thiadiazoles via regioselective [3+2] cycloaddition of nitrile imines to polyfluoroalkanethioamides. Chem. Heterocycl. Compd. 2017, 53(11), 1268-1276.
126 *Vilšķērsts R.; Dambrova G.; Mezhapuke R.; Bandere D.; Dambrova M. Resveratrol attenuates the development of sodium hypochlorite-induced endothelial dysfunction. Nat. Prod. J. 2017, 7(4), 276-280.
127 *Bolsakova J.; Jirgensons A. The Ritter reaction for the synthesis of heterocycles. Chem. Heterocycl. Compd. 2017, 53(11), 1167-1177.
128 *Arsenyan P.; Vasiļjeva J. Selenazolium salts as catalysts in oxidation reactions. Mendeleev Commun. 2017, 27(6), 621-622.
129 *Mierina I.; Jure M.; Zeberga S.; Makareviciene V.; Zicane D.; Tetere Z.; Rāviņa I. Novel type of carbon-centered antioxidants arylmethyl Meldrum's acids − inhibit free radicals. Eur. J. Lipid Sci. Technol. 2017, 119(11).
130 *Zarins A.; Valtenbergs O.; Kizane G.; Supe A.; Tamulevičius S.; Andrulevičius M.; Pajuste E.; Baumane L.; Leys O.; Kolb M.H.H.; Knitter R. Characterisation and radiolysis of modified lithium orthosilicate pebbles with noble metal impurities. Fusion Eng Des 2017, 124, 934-939.
131 Skvarnavicius G.; Toleikis Z.; Grigaliunas M.; Smirnoviene J.; Norvaisas P.; Cimmperman P.; Matulis D.; Petrauskas V. High pressure spectrofluorimetry - A tool to determine protein-ligand binding volume. J. Phys. Conf. Ser. 2017, 950(4).
132 Koleda O.; Broese T.; Noetzel J.; *Roemelt M.; Suna E.; Francke R. Synthesis of Benzoxazoles Using Electrochemically Generated Hypervalent Iodine. J. Org. Chem. 2017, 82(22), 11669-11681.
133 Pikun N.V.; Mykhaylychenko S.S.; *Shermolovich Y.G. The synthesis of fluorine-containing endothiopeptide analogs by the reaction of perfluorinated dithiocarboxylic acid amides with esters of α-amino acids and dipeptides. Arkivoc 2017, 2018(3), 36-44.
134 Chen G.; Abelein A.; Nilsson H.E.; Leppert A.; Andrade-Talavera Y.; Tambaro S.; Hemmingsson L.; Roshan F.; Landreh M.; Biverstal H.; Koeck P.J.B.; Presto J.; Hebert H.; Fisahn A.; *Johansson J. Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state. Nat. Commun. 2017, 8(1).
135 Mahmoud A.B.A.; *Kirsch G.; Peagle E. Biologically active selenophenes and benzo[b]selenophenes. Curr. Org. Synth. 2017, 14(8), 1091-1101.
136 *Konrāde I.; Kalere I.; Strele I.; Makrecka-Kuka M.; Veisa V.; Gavars D.; Rezeberga D.; Pīrāgs V.; Lejnieks A.; Gruntmanis U.; Neimane L.; Liepiņš E.; Dambrova M. Iodine deficiency in Latvia: Current status and need for national recommendations. Proc. Latv. Acad. Sci., Sect. B Nat. Exact. Appl. Sci. 2017, 71(6), 401-407.
137 Rendekova J.; Vlasakova D.; *Arsenyan P.; Vasiļjeva J.; Nasim M.J.; Witek K.; Dominguez-Alvarez E.; Zeslawska E.; Manikova D.; Tejchman W.; Saleem R.S.Z.; Rory K.; Handzlik J.; Chovanec M. The selenium-nitrogen bond as basis for reactive selenium species with pronounced antimicrobial activity. Curr. Org. Synth. 2017, 14(8), 1082-1090.
138 *Ābele E.; Golomba L.; Abele R. 2-mercaptobenzoxazole as a novel sulfur transfer agent in the cu-catalysed “on-water” synthesis of symmetrical or unsymmetrical sulfides under phase transfer catalysis conditions. Curr. Org. Synth. 2017, 14(8), 1193-1197.
139 *Pustenko A.; Žalubovskis R. (Figure presented.) Recent advances in sultone synthesis (microreview). Chem. Heterocycl. Compd. 2017, 53(12), 1283-1285.
140 Witek K.; Nasim M.J.; Bischoff M.; Gaupp R.; Arsenyan P.; Vasiļjeva J.; Marc M.A.; Olejarz A.; Latacz G.; Kiec-Kononowicz K.; *Handzlik J.; Jacob C. Selenazolinium salts as “small molecule catalysts” with high potency against ESKAPE bacterial pathogens. Molecules 2017, 22(12).
141 *Makrecka-Kuka M.; Sevostjanovs E.; Vilks K.; Volska K.; Antone U.; Kūka J.; Makarova E.; Pugovičs O.; Dambrova M.; Liepinsh E. Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. Sci. Rep. 2017, 7(1).
142 Stonans Ilmars; Dambrova Maija; Liepins Edgars; Kalvins Ivars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... SMT201600416, 10.01.2017.
143 Stonans Ilmars; Misane Ilga; Svalbe Baiba; Dambrova Maija; Zvejniece Liga; Kalvins Ivars; Veinbergs Grigorijs. Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. EP3127539, 08.02.2017.
144 Stonans Ilmars; Misane Ilga; Svalbe Baiba; Dambrova Maija; Zvejniece Liga; Kalvins Ivars; Veinbergs Grigorijs; Cernobrovijs Aleksandrs; Vorona Maksims. Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. CA2988045, 09.02.2017.
145 Stonans Ilmars; Misane Ilga; Svalbe Baiba; Dambrova Maija; Zvejniece Liga; Kalvins Ivars; Veinbergs Grigorijs; Cernobrovijs Aleksandrs; Vorona Maksims; - WIPO OMPI. Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. WO2017021881, 09.02.2017.
146 Pelss Janis; Domracheva Ilona; Zalubovskis Raivis; Jaudzems Kristaps. Derivatives of 2,6-diaza-bicyclo2.2.2.octane-3,5-ditione as potential anti cancer agents. LV15160, 20.02.2017.
147 Lebedevs Antons; Ponomarjovs Jurijs; Varaceva Larisa; Cernaks Dmitrijs; Cernobrovijs Aleksandrs. Ibrutiniba izejvielas iegusanas panemiens. WO2017039425, 09.03.2017.
148 Kalvins Ivars; Veinbergs Grigorijs; Vorona Maksims; Zvejniece Liga; Cernobrovijs Aleksandrs; Karina Ligita; Dambrova Maija. Method of preparation and use of pharmacologically active N-carbamoylmethyl-4(R)-phenyl-2-pyrroli.... HRP20090524, 10.03.2017.
149 Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. BR112016000874, 21.03.2017.
150 Zvejniece Liga; Dambrova Maija; Veinbergs Grigorijs; Vorona Maksims; Kalvins Ivars. Pharmaceutical composition for the prevention and treatment of diseases associated with elevated.... EP3142662, 22.03.2017.
151 Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. HK1219500, 07.04.2017.
152 Kinena Linda; Ozola Vita; Suna Edgars; Leitis Gundars; Jaudzems Kristaps; Jirgensons Aigars; Kanepe-Lapsa Iveta; Domracheva Ilona. Novel substituted aminoalkylazoles as malarial aspartic protease inhibitors. WO2017069601, 27.04.2017.
153 Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis; Kalvins Ivars. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... PL2702033, 28.04.2017.
154 Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis; Kalvins Ivars. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... HUE030415, 29.05.2017.
155 Kalvins Ivars; Stonans Ilmars; Dambrova Maija; Liepins Edgars; Cirule Helena; Misane Ilga; Makarova Elina. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or pharmaceutically acceptable salt thereof.... ZA201600894, 31.05.2017.
156 Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. MD4480, 31.05.2017.
157 Lebedevs Antons; Ponomarjovs Jurijs; Varaceva Larisa; Cernaks Dmitrijs; Cernobrovijs Aleksandrs; Lavrinovics Edvards. Ibrutiniba izejvielas iegusanas panemiens. LV15201, 20.07.2017.
158 Liepins Edgars; Dambrova Maija; Makrecka-Kuka Marina; Kuka Janis; Makarova Elina; Sevostjanovs Eduards. Metode insulina rezistences diagnostikai, izmantojot acilkarnitinu koncentraciju noteiksanu asinis. LV15206, 20.07.2017.
159 Rostoka Evita; Sokolovska Jelizaveta; Sjakste Nikolajs; Sjakste Tatjana; Osina Kristine. 1,4-Dihidropiridina atvasinajums DNS parravumu noversanai cukura diabeta apstaklos. LV15181, 20.07.2017.
160 Zvejniece Liga; Dambrova Maija; Veinbergs Grigorijs; Vorona Maksims; Kalvins Ivars. Pharmaceutical composition for the prevention and treatment of diseases associated with elevated.... UA115010, 28.08.2017.
161 Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. LV15257, 20.09.2017.
162 Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide; Drug Design Oxford. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. AU2016216782, 28.09.2017.
163 Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. CN107257789, 17.10.2017.
164 Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide; Drug Design Oxford. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. KR20170118106, 24.10.2017.
165 Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. GEP201706763, 25.10.2017.
166 Kalvins Ivars; Makarova Elina; Sevostjanovs Eduards; Dambrova Maija; Pugovics Osvalds; Liepins Edgars; Grinberga Solveiga. Pharmaceutical composition for reducing trimethylamine N-oxide level. GEP6747, 10.11.2017.
167 Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. EP3259250, 27.12.2017.
168 Kreicberga A.; Kazoka H.; Orlova N.; Veinberg G.; Vorona M. Stationary Phase Selection for Achiral Separation of Disubstituted Piracetam Diastereomeric Mixtures. Chromatography today 2017, 10(4), 10-14.
169 Cipa J.; Kizane G.; Supe A.; Zolotarjovs A.; Zarins A.; Baumane L. Luminescence of X-ray induced radiation defects in modiﬁed lithium orthosilicate pebbles with additions of titanium dioxide. Energetika 2017, 3, 113-120.
170 *Петухов В.И.; Баумане Л.Х.; Калвиньш И.Я.; Романова М.А.; Быкова Е.А.; Хемий Л.Р. ЭПР-АНАЛИЗ КОЛИЧЕСТВА НИТРОКСИДА В ЭПИДЕРМИСЕ НА ФОНЕ ПРИЕМА МИЛДРОНАТА: СВЯЗЬ С УРОВНЕМ СЫВОРОТОЧНОГО ФЕРРИТИНА (DOI: 10.19112/2413-6174-2017-18-3-30-35). 2017, 18(3), 30-35.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V.